**
A comprehensive analysis has raised alarming concerns regarding the potential impact of policies enacted during Donald Trump’s administration on lung health across the United States. Researchers, including pulmonary specialists and public health experts, argue that recent legislative changes could lead to a significant surge in lung diseases and premature deaths. The findings, published in the *American Journal of Respiratory and Critical Care Medicine*, underscore a troubling intersection of healthcare access, environmental regulations, and public health initiatives.
Policies Under Scrutiny
The study scrutinises ten key policy areas, including healthcare access, environmental protections, and workplace safety measures enacted during Trump’s second term. Experts warn that these changes could exacerbate existing health conditions, hinder access to crucial medical care, and ultimately threaten the pulmonary health of both adults and children. Lead researcher Adam Gaffney, a pulmonary physician and professor at Harvard Medical School, characterised the situation as an “attack on Americans’ lungs,” predicting that millions may face unnecessary fatalities in the coming years.
In response to these findings, White House spokesperson Kush Desai asserted, “The Trump administration is not jeopardising healthcare access for anyone.”
Financial Cuts and Healthcare Access
A primary concern outlined in the study is the substantial cuts to healthcare funding included in Trump’s second-term tax and spending package, known as the One Big Beautiful Bill Act (OBBBA). This legislation slashed more than $1 trillion from health programmes, marking the most significant federal healthcare reductions in American history. Gaffney highlighted the potential consequences for patients, particularly those reliant on Medicaid. “When you take away access to modern medicine, it does harm,” he stated, emphasising that patients with chronic conditions could face dire outcomes without adequate healthcare coverage.
Desai defended the OBBBA, claiming it introduces “commonsense work requirements” and reforms aimed at reducing waste in Medicaid, thereby strengthening the programme for those who depend on it.
Environmental Rollbacks and Public Health
In addition to healthcare cuts, the Trump administration has rolled back numerous air quality standards, including those regulating soot and airborne mercury emissions. These changes, while beneficial for certain industries, are projected to result in increased asthma cases and hospital admissions related to respiratory illnesses. Mary Rice, director of the Centre for Climate, Health, and the Global Environment at Harvard, argued that prioritising economic gains for polluters over clean air endangers the respiratory health of countless Americans.
The analysis also pointed to delays in clean energy projects and efforts to undermine California’s authority over electric vehicle sales, warning that these actions could have irreversible consequences for lung health.
Compounding Risks for Vulnerable Populations
The report highlights the compounded risks faced by individuals exposed to multiple health threats. For example, a patient suffering from chronic obstructive pulmonary disease (COPD) may find their situation worsened by both loss of healthcare coverage and increased exposure to air pollution due to weakened emissions standards. Furthermore, cuts to public health funding at agencies like the CDC could hinder access to critical services, such as tobacco cessation programmes, which are vital for those at risk.
The study also notes that certain demographic groups, particularly low-income communities and people of colour, are likely to bear the brunt of these policy changes. Gaffney remarked, “We have a very unequal society in many respects, and we know lung disease disproportionately affects working-class people across all races.”
Why it Matters
These findings illuminate the far-reaching impact of federal policies on public health, particularly concerning lung disease. With the potential to affect millions, particularly the most vulnerable populations, the combination of healthcare cuts and environmental rollbacks poses a significant threat to respiratory health in the United States. As experts call for a return to public health-focused missions within federal agencies, it becomes clear that a proactive approach is essential to safeguard the health and wellbeing of all Americans. As we navigate these complex issues, the imperative for comprehensive healthcare reform and robust environmental protections has never been clearer.
